Form 8-K - Current report:
SEC Accession No. 0001104659-21-119299
Filing Date
2021-09-24
Accepted
2021-09-24 16:10:56
Documents
12
Period of Report
2021-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128375d1_8k.htm   iXBRL 8-K 25483
  Complete submission text file 0001104659-21-119299.txt   200448

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nxtc-20210921.xsd EX-101.SCH 3189
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nxtc-20210921_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nxtc-20210921_pre.xml EX-101.PRE 22713
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2128375d1_8k_htm.xml XML 3722
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 211277374
SIC: 2834 Pharmaceutical Preparations